These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 34354868)

  • 21. The methylation modification of m6A regulators contributes to the prognosis of head and neck squamous cell carcinoma.
    Chen Y; Jiang X; Li X; Yan D; Liu J; Yang J; Yan S
    Ann Transl Med; 2021 Aug; 9(16):1346. PubMed ID: 34532483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expressions of m6A RNA methylation regulators and their clinical predictive value in cervical squamous cell carcinoma and endometrial adenocarcinoma.
    Wu H; Dong H; Fu Y; Tang Y; Dai M; Chen Y; Wang G; Wu Y
    Clin Exp Pharmacol Physiol; 2021 Feb; 48(2):270-278. PubMed ID: 33006785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N6-Methyladenosine RNA Methylation Regulator-Related Alternative Splicing (AS) Gene Signature Predicts Non-Small Cell Lung Cancer Prognosis.
    Zhao Z; Cai Q; Zhang P; He B; Peng X; Tu G; Peng W; Wang L; Yu F; Wang X
    Front Mol Biosci; 2021; 8():657087. PubMed ID: 34179079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular Characteristics, Prognostic Value, and Immune Characteristics of m
    Geng X; Zhang Y; Zeng Z; Zhu Z; Wang H; Yu W; Li Q
    Front Oncol; 2021; 11():629718. PubMed ID: 33816266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive Investigation of m6A Regulators for Prognosis in Head and Neck Squamous Cell Carcinoma.
    Cheng J; Lyu Y; Cheng Z
    J Environ Pathol Toxicol Oncol; 2024; 43(1):45-60. PubMed ID: 37824369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. m6A-Related Genes Contribute to Poor Prognosis of Hepatocellular Carcinoma.
    Zou Y; Jiang G; Xie Y; Li H
    Comput Math Methods Med; 2022; 2022():2427987. PubMed ID: 36339682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive Analysis of the Prognostic Role and Mutational Characteristics of m6A-Related Genes in Lung Squamous Cell Carcinoma.
    Gu C; Shi X; Qiu W; Huang Z; Yu Y; Shen F; Chen Y; Pan X
    Front Cell Dev Biol; 2021; 9():661792. PubMed ID: 33842487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N6-methyladenosine RNA methylation regulator-related alternative splicing gene signature as prognostic predictor and in immune microenvironment characterization of patients with low-grade glioma.
    Maimaiti A; Tuersunniyazi A; Meng X; Pei Y; Ji W; Feng Z; Jiang L; Wang Z; Kasimu M; Wang Y; Shi X
    Front Genet; 2022; 13():872186. PubMed ID: 35937991
    [No Abstract]   [Full Text] [Related]  

  • 29. Prognostic and therapeutic implication of m6A methylation in Crohn disease.
    He Y; Hu Y; Yuan M; Xu W; Du Y; Liu J
    Medicine (Baltimore); 2022 Dec; 101(51):e32399. PubMed ID: 36595818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics of n6-methyladenosine (m6A) regulators and role of FTO/TNC in scleroderma.
    Yu Y; Liang C; Tang Q; Shi Y; Shen L
    Gene; 2024 Feb; 894():147989. PubMed ID: 37972699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and significance of m6A-RNA-methylation in oral cancer and precancerous lesion.
    Qin Z; Bai J; He H; Li B
    Front Oncol; 2023; 13():1013054. PubMed ID: 36793593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and Prognostic Pan-Cancer Analysis of N6-Methyladenosine Regulators in Two Types of Hematological Malignancies: A Retrospective Study Based on TCGA and GTEx Databases.
    Zhang X; Zhong L; Zou Z; Liang G; Tang Z; Li K; Tan S; Huang Y; Zhu X
    Front Oncol; 2021; 11():623170. PubMed ID: 33816257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IGF2BP2 promotes pancreatic carcinoma progression by enhancing the stability of B3GNT6 mRNA via m6A methylation.
    Cao P; Wu Y; Sun D; Zhang W; Qiu J; Tang Z; Xue X; Qin L
    Cancer Med; 2023 Feb; 12(4):4405-4420. PubMed ID: 35908253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IGF2BP2 serves as a core m6A regulator in head and neck squamous cell carcinoma.
    Hu Y; Chen J; Liu M; Feng Q; Peng H
    Biosci Rep; 2022 Nov; 42(11):. PubMed ID: 36281789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigating the prognostic value of m6A methylation-related genes in renal cell carcinoma patients.
    Ge GC; Wang CH
    Eur Rev Med Pharmacol Sci; 2023 Dec; 27(24):11932-11946. PubMed ID: 38164857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of an m6A-Related Signature as Biomarker for Hepatocellular Carcinoma Prognosis and Correlates with Sorafenib and Anti-PD-1 Immunotherapy Treatment Response.
    Jiang H; Ning G; Wang Y; Lv W
    Dis Markers; 2021; 2021():5576683. PubMed ID: 34221187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive Analysis of Expression Regulation for RNA m6A Regulators With Clinical Significance in Human Cancers.
    Liu X; Wang P; Teng X; Zhang Z; Song S
    Front Oncol; 2021; 11():624395. PubMed ID: 33718187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploring the role of m6A methylation regulators in glioblastoma multiforme and their impact on the tumor immune microenvironment.
    Deng X; Sun X; Hu Z; Wu Y; Zhou C; Sun J; Gao X; Huang Y
    FASEB J; 2023 Sep; 37(9):e23155. PubMed ID: 37606566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression and Prognostic Significance of m6A-Related Genes in Lung Adenocarcinoma.
    Zhang Y; Liu X; Liu L; Li J; Hu Q; Sun R
    Med Sci Monit; 2020 Feb; 26():e919644. PubMed ID: 32086933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive Analysis of N6-Methyladenosine (m6A) Writers, Erasers, and Readers in Cervical Cancer.
    Condic M; Ralser DJ; Klümper N; Ellinger J; Qureischi M; Egger EK; Kristiansen G; Mustea A; Thiesler T
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.